RPL41

Small ribosomal subunit protein eS32 (60S rib · P62945 · RPL41 on Sugi Atlas →

0 patent compounds predicted against RPL41, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL41 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World PHASE4UNKNOWN
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer PHASE2COMPLETED
Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer PHASE1/PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1WITHDRAWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) nanRECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Testing of Micellar Casein, Blended Micellar Casein and Native Whey nanCOMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
RibOSE - Glucose and Resistance Exercise Training nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Control Ovarian Stimulation Timing Test nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a RPL41 binder may also engage these)

ProteinNameSimilarity
Q71H53 0.995 Q71H53 →
P62947 0.995 P62947 →
Q6YLX4 0.990 Q6YLX4 →
P62946 0.978 P62946 →
Q5RFG9 0.978 Q5RFG9 →
P62949 0.978 P62949 →
A0A087WNH4 0.978 A0A087WNH4 →
P62948 0.976 P62948 →
P62125 0.973 P62125 →
Q7KF89 0.972 Q7KF89 →
P0CT82 0.968 P0CT82 →
P62124 0.967 P62124 →
P62121 0.967 P62121 →
P62120 0.967 P62120 →
P62123 0.966 P62123 →
P62122 0.966 P62122 →
P0CT81 0.961 P0CT81 →
Q90YS7 0.956 Q90YS7 →
O82713 0.955 O82713 →
Q75AH3 0.944 Q75AH3 →
P0CX86 0.942 P0CX86 →
P0CX87 0.939 P0CX87 →
P9WER7 0.938 P9WER7 →
P78569 0.935 P78569 →
P9WKT5 0.886 P9WKT5 →
P9WKT4 0.884 P9WKT4 →
P0A5D0 0.882 P0A5D0 →
O49224 0.862 O49224 →
Q9DFR4 0.753 Q9DFR4 →
Q9GRJ3 0.747 Q9GRJ3 →